Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS) Ghady Haidar , Mounzer Agha , Andrew Bilderback , Amy Lukanski , Kelsey Linstrum , Rachel Troyan , Scott Rothenberger , Deborah K. McMahon , Melissa D. Crandall , Michele D. Sobolewksi , P. Nathan Enick , Jana L. Jacobs , Kevin Collins , Cynthia Klamar-Blain , Bernard J. C. Macatangay , Urvi M. Parikh , Amy Heaps , Lindsay Coughenour , Marc B. Schwartz , Jeffrey M. Dueker , Fernanda P. Silveira , Mary E. Keebler , Abhinav Humar , James D. Luketich , Matthew R. Morrell , Joseph M. Pilewski , John F. McDyer , Bhanu Pappu , Robert L. Ferris , Stanley M. Marks , John Mahon , Katie Mulvey , Sundaram Hariharan , Glenn M. Updike , Lorraine Brock , Robert Edwards , Richard H. Beigi , Paula L. Kip , Alan Wells , Tami Minnier , Derek C. Angus , John W. Mellors Clinical infectious diseases an official publication of the Infectious Diseases Society of America（2022）
Key words
COVID-19 vaccines, SARS-COV-2 antibody, immunocompromised, SARS-CoV-2 neutralization
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
